Content area
Full Text
Bristol-Myers Squibb Co. has decided that the only business it wants to be in is pharmaceuticals, and the company has been taking steps to shed non-core operations so that it can devote its attention and resources to its drug business.
Earlier this year the company said it would sell or spin off its Warsaw, Ind.-based Zimmer Inc. unit, maker of orthopedic implants, and recently announced that it is selling its Clairol hair care line to Procter & Gamble Co. for nearly $5 billion.
Both businesses are profitable....